Home › Mga Karamdaman ng Isip › Texas
Pag-aaral pangklinika para sa Mga Karamdaman ng Isip sa Texas
7 pag-aaral para sa Mga Karamdaman ng Isip ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT04366531Targeted Plasticity Therapy for PTSD
- The University of Texas Health Austin Ambulatory Surgery Center, Austin
- Baylor University Medical Center, Dallas
- Texas Biomedical Device Center, Richardson
Nagre-recruit
Edad 22 hanggang 79 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06266364A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Austin, Texas, Austin
- Dallas, Texas, Dallas
- San Antonio, Texas, San Antonio
- at 1 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07598708A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Austin
- Clinical Site, DeSoto
- Clinical Site, Richardson
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07459647A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
Nagre-recruitPhase 2
Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06887192A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Biobehavioral Research of Austin, Austin
- InSite Clinical Research, DeSoto
- Aim Trials, LLC, Plano
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 11, 2026 · NCT06524830Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
Nagre-recruitPhase 2
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.